View Older Stories

Aug 20, 2026 02:49AM UBS Downgrades Merck (MRK) to Neutral

Aug 19, 2026 04:23PM Moderna (MRNA) PT Raised to $89 at Morgan Stanley

Aug 19, 2026 04:22PM Morgan Stanley Upgrades Merck (MRK) to Overweight

Aug 19, 2026 11:22AM Merck (MRK) call put ratio 3.1 calls to 1 put after INTerpath-001 trial results

Aug 19, 2026 09:17AM Merck (MRK) call put ratio 1.4 calls to 1 put into INTerpath-001 trial results

Aug 19, 2026 08:11AM William Blair Upgrades Moderna (MRNA) to Outperform, 'we believe Moderna has a clear line of sight to revenue diversification from the COVID business

Aug 19, 2026 07:03AM Moderna shares soar on melanoma drug trial success

Aug 11, 2026 07:12AM Merck (MRK) PT Raised to $145 at Argus

Aug 6, 2026 04:36PM Trump Administration Weighs Order On Autism And Vaccines - Bloomberg

Aug 6, 2026 06:45AM FDA accepts Merck's sBLA for Enflonsia to cover second RSV season

Aug 4, 2026 06:47AM Merck shares rise on big Q2 earnings beat, adjusted FY outlook

Aug 4, 2026 06:33AM Merck (MRK) Tops Q2 EPS by 14c, Beats on Revenue; Offers FY26 EPS Guidance

Aug 3, 2026 10:33AM Merck (MRK) call put ratio 1.2 calls to 1 put into quarter results

Aug 3, 2026 06:05AM Merck (MRK) call put ratio 1.3 calls to 1 put into quarter results

Aug 1, 2026 10:00AM U.S. biopharma earnings: Eli Lilly (LLY), Pfizer (PFE) take the stage

Jul 31, 2026 11:02AM Merck (MRK) call put ratio 2 calls to 1 put into quarter results

Jul 29, 2026 11:04AM Merck (MRK) Declares $0.85 Quarterly Dividend; 2.6% Yield

Jul 27, 2026 09:29AM Merck (MRK) PT Raised to $105 at Bernstein SocGen Group

Jul 21, 2026 10:00AM Gilead to present lenacapavir HIV trial data at AIDS 2026

Jul 21, 2026 06:13AM Phanes expands Merck collaboration to study cancer drug combination

Jul 17, 2026 07:07AM Guggenheim Reiterates Buy Rating on Merck (MRK)

Jul 16, 2026 03:28PM Personalis (PSNL) explores potential sale after interest from Merck and others - source

Jul 16, 2026 06:45AM FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor

Jul 16, 2026 06:39AM Guggenheim Reiterates Buy Rating on Merck (MRK)

Jul 13, 2026 07:58AM Merck (MRK) PT Raised to $142 at BMO Capital

Jul 13, 2026 06:53AM Merck (MRK) PT Raised to $145 at Guggenheim

Jul 8, 2026 06:08AM Merck (MRK) PT Raised to $113 at Morgan Stanley

Jun 30, 2026 07:20AM Merck (MRK) PT Raised to $155 at Scotiabank

Jun 30, 2026 06:02AM U.S. House committee opens investigation into Merck, AbbVie China drug trials - Reuters

Jun 30, 2026 05:23AM Merck (MRK) PT Raised to $141 at BofA Securities

Jun 29, 2026 06:45AM Merck reaches deal to expand HIV drug access via ADAP programs

Jun 17, 2026 11:15AM Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says

Jun 15, 2026 06:08AM German government to drop variable drug discounting plans - Reuters

Jun 2, 2026 07:23AM Merck (MRK) Reiterated at Neutral by Cantor Fitzgerald

Jun 2, 2026 06:48AM Guggenheim Reiterates Buy Rating on Merck (MRK)

Jun 1, 2026 08:01AM Moderna and Merck report sustained melanoma treatment benefits at 5 years

Jun 1, 2026 08:00AM Moderna and Merck Present 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA (pembrolizumab) in Patients With High-Risk Stage III/IV Melanoma Following Complete Resection at the 2026 ASC

May 29, 2026 06:49AM FDA grants breakthrough therapy designation to Merck's KRAS G12C inhibitor

May 26, 2026 01:28PM Merck (MRK) Declares $0.85 Quarterly Dividend; 2.8% Yield

May 22, 2026 09:54AM China holds roundtable with over 50 foreign pharmaceutical firms

May 22, 2026 09:25AM China Commerce Ministry holding meeting with foreign pharma companies including Lilly, Sanofi, Novartis, Merck

May 18, 2026 10:59AM Trump to unveil more discounted prescription drug options - CNBC

May 18, 2026 06:46AM Merck endometrial cancer drug meets survival goals in phase 3 trial

May 12, 2026 06:45AM Merck to present oncology data across 25 cancer types at ASCO 2026

May 7, 2026 02:12PM Merck publishes synthesis method for oral PCSK9 inhibitor in Science

May 6, 2026 05:01AM Citi Reinstates Merck (MRK) at Neutral

Apr 30, 2026 06:32AM Merck (MRK) Tops Q1 EPS by 20c; offers guidance

Apr 29, 2026 11:21AM Merck (MRK) call put ratio 1.4 calls to 1 put into quarter results

Apr 29, 2026 04:41AM Merck (MRK) call put ratio 1 call to 1.4 puts into quarter results

Apr 27, 2026 06:42AM Guggenheim Reiterates Buy Rating on Merck (MRK)

View Older Stories